Dr Lavanya Diwakar MSc, MRCP

Research Fellow, Health Economics

Health Economics

Contact details

Health Economics Unit
School of Health and Population Sciences
Public Health Building
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

About

Lavanya Diwakar is a doctor trained in allergy and immunology. She is currently working with the Health Economics Unit as a research fellow.

Under the supervision of Prof.Tracy Roberts and Dr.Pelham Barton, Lavanya has completed on the health economics of the PLUTO trial, which is a HTA funded neonatology trial looking at the cost effectiveness of intrauterine intervention for lower urinary tract obstruction. She is now working on the economic analysis of the OPT (Outpatient Polyp Treatment) trial for patients with abnormal uterine bleeding.

She is due to start a Wellcome trust funded Research fellowship carrying out "An economic evaluation of Paediatric Allergy services in the West Midlands" later this year. She will be employed as a honorary consulant in Immunology at the Queen Elizabeth Hospital for the duration of this fellowship.

Qualifications

  • MSc (Health economics and Health policy), University of Birmingham 2010
  • Member of Royal College of Physicians (UK) 2004
  • General Medial Council (UK) 2001

Other activities

Specialist registrar in Immunology, Heartlands Hospital Birmingham

Publications

Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. (Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, Nasser SM.) Clin Exp Allergy. 2011 Sep;41(9): 1201-20.

Retrospective case series analysis of penicillin allergy testing in a UK specialist regional allergy clinic. (Richter AG, Wong G, Goddard S, Heslegrave J, Derbridge C, Srivastava S, Diwakar L, Huissoon AP, Krishna MT.) J Clin Pathol. 2011 Jul 8. [Epub ahead of print]

Self-injectable adrenaline devices: is training necessary? (Diwakar L, Heslegrave J, Richter AG, Huissoon AP, Krishna MT.) J Investig Allergol Clin Immunol. 2010;20(5):452-3.

Does rituximab aggravate pre-existing hypogammaglobulinaemia?
(Diwakar L, Gorrie S, Richter A, Chapman O, Dhillon P, Al-Ghanmi F, Noorani S, Krishna MT, Huissoon A) J Clin Pathol. 2010 Mar;63(3):275-7.

Practice of venom immunotherapy in the United Kingdom: a national audit and review of literature (Diwakar L, Noorani S et al) Clin Exp Allergy, 2008 (38) 1651-58

Enhanced Ex vivo stimulation of M. tuberculosis-specific T cells in HIV-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector (Connell TG, Shey MS, Seldon R, Rangaka MX, Diwakar L et al) Clin Vaccine Immunol. 2007 Jul;14(7):847-54.

Clinical, Immunological and Epidemiological importance of Anti-Tuberculosis T cell responses in HIV infected Africans (Diwakar.L, Rangaka.M.X et al)Clin Infect Dis. 2007 Jun 15;44(12):1639-46.

Effect of HIV-1 infection on T-cell based and skin test detection of tuberculosis infection (Rangaka MX, Wilkinson KA, Diwakar L et al) Am J Respir Crit Care Med Vol 175. pp 514–520, 2007

Back to top